Skip to main content
. 2018 Jun 7;9(6):680. doi: 10.1038/s41419-018-0738-z

Fig. 2. miR-16-5p suppressed cell proliferation in vitro and vivo.

Fig. 2

a Cell proliferation was evaluated by the CCK-8 assay at 24, 48 and 72 h. b The effects of miR-16-5p on the cell cycle were determined by flow cytometry (FCM). c FCM indicated G0/G1-phase arrest of the cell cycle in cells transfected with miR-16-5p mimics. d Tumor volume was significantly decreased in the miR-16-5p agomir treatment group compared with the control group. e Representative images of H&E staining of tumors formed by U-CH1 cells. f qRT-PCR results showing that miR-16-5p was significantly upregulated in the miR-16-5p agomir treatment group compared with the control group. g The tumor volume was measured every 7 days, and the growth curves of the tumors were plotted accordingly. **p < 0.01.